Managing Pain in the 21st Century

Slides:

Advertisements

Similar presentations

Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.

Advertisements

An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.

People with chronic pain are often prescribed methadone, a type of analgesic medicine to reduce pain. This medicine is also given.

List Three Mechanisms by which Chronic Opioid Therapy Can Worsen Pain

Multimodal Management of Opioid-Induced Constipation

STOP! Safe Treatment of Pain

A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,

PrEP: A Case-by-Case Approach

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.

Medication Effects That May Impair Driving Ability

Maximizing Medical Management of Knee Osteoarthritis

Optimizing Therapy for Osteoarthritis

HCV: Who Should We Screen and Why?

Cardiogenic Shock.

Heart Rate, HF Admissions, and Readmissions

Thrombosis, Cancer, and NOACs

This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.

The Nurse View.

Progression After Cancer Immunotherapy in Advanced NSCLC

MANAGING GLAUCOMA:.

Fresh Perspectives on oral contraception

Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.

Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?

The Latest Data on Oral Prostacyclin Therapy in PAH

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

The Cancer Pain Journey: Optimizing Identification and Management

The Vicious Cycle of Chronic Migraine How Can the Physician Help?

Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.

Tailoring Hemophilia Prophylaxis Therapy

Counseling Patients About Germline BRCA Mutations

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Evaluating LDL-C Recommendations

From Symptom Management to Communication in Advanced GI Cancers

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis

Gene Therapy: Past, Present, and Future

Improving Appropriate Access to PCSK9 Inhibitors

OTC NSAID Use in Patients With OA and CV Disease

Statins and HIV:.

Ask the Experts.

Program Goals Overview Glatiramer Acetate 3 Times a Week.

Immunotherapy for cSCC

Perspectives on the Impact of Inflammation in OA

An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

Parkinson Disease Psychosis

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

When to Start and What to Use

Medication Risks for Older Drivers

When Is Intrathecal Drug Delivery Appropriate?

Cancer-Associated Thrombosis

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Patient Questions and Expert Answers in Psoriasis:

A Guideline-Based Approach to HCV Care

Insulin in Diabetes Management: Effective Patient Selection Is Key

Critical Decision Points in Insomnia

Add-On Therapy to Insulin in T1DM Management

Update on OTC Pain Relievers for Osteoarthritis

Program Goal. Program Goal Disclaimer Overview.

When Is Intrathecal Drug Delivery Appropriate?

Transitioning Therapy in PAH: Practical Strategies and Considerations

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia.

Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.

Expert Perspectives.

Comprehensive Acne Management

Updates in Best Practices in Non-Small Cell Lung Cancer

Presentation transcript:

Managing Pain in the 21st Century

Overview of Chronic Pain in the United States

Rates of Chronic Pain Are Increasing for a Variety of Reasons

Mechanistic Characterization of Pain

Opioid Epidemic in the United States

Opioids for Chronic Low Back Pain Meta-Analysis

Opioids for Chronic Non-Cancer Pain Meta-Analysis

Opioid vs Non-Opioid Analgesics SPACE Trial Design

Opioid vs Non-Opioid Analgesics SPACE Trial Results

CDC Guidelines for Opioid Prescribing

Opioids for Chronic Low Back Pain ACP Guidelines

Opioids for Chronic Pain Summary

Medication Options for Chronic Pain by Pain Type

Approach to Medications for Chronic Pain

Non-Opioid Options for Pain

Topical Therapies for Chronic Pain

Acetaminophen

Acetaminophen for Back Pain or OA

Oral NSAIDs

Considerations for Prescribing Oral NSAIDs

CV Risks With NSAIDs

Antidepressants for Chronic Pain Overview

Antidepressants for Chronic Pain by Class

SNRIs

Tramadol

Gabapentinoids

Muscle Relaxants/Antispasticity Agents

Evidence-Based Recommendations for Chronic Low Back Pain

Recommendations for Knee/Hip OA

Pain Management Team

Team-Based Approach to Chronic Pain Management

Concluding Remarks

Abbreviations

Abbreviations (cont)